Loading viewer...
investor_presentation
Format: PDF investor_presentation
ITC's Q1 FY2023 investor and analyst presentation delivered on August 3, 2022, outlining the company's strategy to drive penetration-led volume growth in health and beauty categories across emerging markets. The update emphasizes ITC's commitment to sustainability leadership and social impact as core business drivers.
brochure
BriaCell Therapeutics Investor Presentation October 2023
investor_presentation
20 Pages
BriaCell Therapeutics Corp.
Healthpeak Properties Investor Presentation June 2023
investor_presentationinvestor_presentation
24 Pages
Healthpeak Properties, Inc.